⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14767840 | 0.76 | — | — | |
| SCHEMBL130679 | 0.74 | — | — | |
| SCHEMBL13093698 | 0.73 | — | — | |
| SCHEMBL13177427 | 0.73 | — | — | |
| SCHEMBL12968370 | 0.73 | — | — | |
| SCHEMBL18533573 | 0.73 | — | — | |
| SCHEMBL19652056 | 0.71 | — | — | |
| SCHEMBL12610916 | 0.71 | — | — | |
| SCHEMBL20145374 | 0.71 | — | — | |
| SCHEMBL14088953 | 0.70 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227437-A1 | IMMUNOMODULATOR | HITGEN INC (CN) | 2023-07-20 | — | — | US | disclosed |
| US-20230159465-A1 | IMMUNOMODULATOR | HITGEN INC. (CN) | 2023-05-25 | — | — | US | disclosed |
| US-9907854-B2 | Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof | CellMosaic, Inc. (US) | 2018-03-06 | — | — | US | disclosed |
| US-20170065726-A1 | NOVEL CROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC BIOCONJUGATES, AND SYNTHETIC METHODS THEREOF | CELLMOSAIC INC (US) | 2017-03-09 | — | — | US | disclosed |
| US-9511150-B2 | Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof | CellMosaic, Inc. (US) | 2016-12-06 | — | — | US | disclosed |
| US-8907079-B2 | Crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof | CELLMOSAIC INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140206903-A1 | NOVELCROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC CONJUGATES, AND SYNTHETIC METHODS THEREOF | CELLMOSAIC INC (US) | 2014-07-24 | — | — | US | disclosed |
| US-20120329958-A1 | POLYMER SYNTHESIS AND THERMALLY REARRANGED POLYMRES AS GAS SEPARATION MEMBRANES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2012-12-27 | — | — | US | disclosed |
| EP-0409118-B1 | Pyrazolines and their use as antidotes | HOECHST SCHERING AGREVO GMBH (DE) | 1994-10-12 | — | — | EP | disclosed |
| EP-0272110-B1 | ERYTHROMYCIN A DERIVATIVES AND METHOD FOR THE PREPARATION OF THE SAME | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1993-04-07 | — | — | EP | disclosed |
| US-5103017-A | PYRAZOLINES AND THEIR USE AS SAFENERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-04-07 | — | — | US | disclosed |
| US-5037468-A | Prevent phytotoxic damage by herbicides | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-08-06 | — | — | US | disclosed |
| US-4990602-A | Bactericides | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| EP-0409118-A1 | Pyrazolines and their use as antidotes | Hoechst Schering AgrEvo GmbH (DE) | 1991-01-23 | — | — | EP | disclosed |
| EP-0272110-A2 | Erythromycin a derivatives and method for the preparation of the same | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1988-06-22 | — | — | EP | disclosed |